Acute-on-chronic liver failure

The Lancet

Volumn 386, Issue 10003, 2015, Pages 1576-1587

  Bernal, William ^a   Jalan, Rajiv ^b,c   Quaglia, Alberto ^a   Simpson, Kenneth ^d   Wendon, Julia ^a   Burroughs, Andrew ^b,c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE ON CHRONIC LIVER FAILURE; ALCOHOL LIVER DISEASE; ARTICLE; BACTERIAL INFECTION; BLOOD CLOTTING DISORDER; BRAIN DISEASE; CHRONIC LIVER DISEASE; CHRONIC LIVER FAILURE CONSORTIUM ORGAN FAILURE SCORE; CLINICAL ASSESSMENT TOOL; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; GRAFT RECIPIENT; HEART FAILURE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INJURY; KIDNEY FAILURE; LIVER FUNCTION; LIVER SUPPORT; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; VIRUS INFECTION; ACUTE-ON-CHRONIC LIVER FAILURE; CARDIOVASCULAR DISEASE; COMPLICATION; ORGAN DYSFUNCTION SCORE; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ACUTE-ON-CHRONIC LIVER FAILURE; BACTERIAL INFECTIONS; BLOOD COAGULATION DISORDERS; BRAIN DISEASES; CARDIOVASCULAR DISEASES; HUMANS; LIVER TRANSPLANTATION; ORGAN DYSFUNCTION SCORES; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 84947306638     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00309-8     Document Type: Review

References (143)

1. JL Dienstag, MG Ghany, TR Morgan the HALT-C Trial Group A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C Hepatology 54 2011 396 405
2. P Jepsen, P Ott, PK Andersen, HT Sørensen, H Vilstrup Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study Hepatology 51 2010 1675 1682
3. G D'Amico, G Garcia-Tsao, L Pagliaro Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies J Hepatol 44 2006 217 231
4. R Moreau, R Jalan, P Gines et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology 144 2013 1426 1437
5. R Jalan, C Yurdaydin, JS Bajaj the World Gastroenterology Organization Working Party Toward an improved definition of acute-on-chronic liver failure Gastroenterology 147 2014 4 10
6. R Jalan, P Gines, JC Olson et al. Acute-on-chronic liver failure J Hepatol 57 2012 1336 1348
7. DL Shawcross, MJ Austin, RD Abeles et al. The impact of organ dysfunction in cirrhosis: survival at a cost? J Hepatol 56 2012 1054 1062
8. JC Olson, JA Wendon, DJ Kramer et al. Intensive care of the patient with cirrhosis Hepatology 54 2011 1864 1872
9. PA Berry, SJ Thomson, TM Rahman, A Ala Review article: towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis Aliment Pharmacol Ther 37 2013 174 182
10. National Confidential Enquiry into Patient Outcome and Death Measuring the Units: a review of patients who died with alcohol-related liver disease 2013 National Confidential Enquiry into Patient Outcome and Death London
11. M Schmidt, A Barritt, E Orman, P Hayashi Decreasing mortality among patients hospitalised with cirrhosis in the United States from 2002 through 2010 Gastroenterology 148 2015 967 977
12. E Cholongitas, V Calvaruso, M Senzolo et al. RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit J Gastroenterol Hepatol 24 2009 1639 1647
13. J Henrion, P Deltenre, S De Maeght et al. Acute upper gastrointestinal bleeding in cirrhosis: changes and advances over the past two decades Acta Gastroenterol Belg 74 2011 381 388
14. MJ McPhail, DL Shawcross, RD Abeles et al. Increased survival for patients with cirrhosis and organ failure in liver intensive care and validation of the chronic liver failure-sequential organ failure scoring system Clin Gastroenterol Hepatol 13 2015 1353 1360
15. KA Wlodzimirow, S Eslami, A Abu-Hanna, M Nieuwoudt, RA Chamuleau A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality Liver Int 33 2013 40 52
16. R Jalan, R Williams Acute-on-chronic liver failure: pathophysiological basis of therapeutic options Blood Purif 20 2002 252 261
17. SK Sarin, A Kumar, JA Almeida et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) Hepatol Int 3 2009 269 282
18. JC Olson, PS Kamath Acute-on-chronic liver failure: concept, natural history, and prognosis Curr Opin Crit Care 17 2011 165 169
19. JS Bajaj, JG O'Leary, KR Reddy the North American Consortium For The Study Of End-Stage Liver Disease (NACSELD) Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures Hepatology 60 2014 250 256
20. JL Vincent, R Moreno, J Takala et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 1996 707 710
21. R Jalan, F Saliba, M Pavesi the CANONIC study investigators of the EASL-CLIF Consortium Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure J Hepatol 61 2014 1038 1047
22. RK Dhiman, S Agrawal, T Gupta, A Duseja, Y Chawla Chronic liver failure-sequential organ failure assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome World J Gastroenterol 20 2014 14934 14941
23. M Lee, JH Lee, S Oh et al. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis Liver Int 35 2015 46 57
24. E Levesque, F Saliba, P Ichaï, D Samuel Outcome of patients with cirrhosis requiring mechanical ventilation in ICU J Hepatol 60 2014 570 578
25. HC Pan, CC Jenq, MH Tsai et al. Scoring systems for 6-month mortality in critically ill cirrhotic patients: a prospective analysis of chronic liver failure - sequential organ failure assessment score (CLIF-SOFA) Aliment Pharmacol Ther 40 2014 1056 1065
26. E Theocharidou, G Pieri, AO Mohammad et al. The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score Am J Gastroenterol 109 2014 554 562
27. R Jalan, M Pavesi, F Saliba the CANONIC Study Investigators; EASL-CLIF Consortium The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure J Hepatol 62 2015 831 840
28. T Gustot, J Fernandez, E Garcia the CANONIC Study Investigators of the EASL-CLIF Consortium Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis Hepatology 62 2015 243 252
29. PS Kamath, WR Kim the Advanced Liver Disease Study Group The model for end-stage liver disease (MELD) Hepatology 45 2007 797 805
30. RN Pugh, IM Murray-Lyon, JL Dawson, MC Pietroni, R Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
31. R Jalan, V Stadlbauer, S Sen, L Cheshire, YM Chang, RP Mookerjee Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study Crit Care 16 2012 R227
32. DC Angus, D Burgner, R Wunderink et al. The PIRO concept: P is for predisposition Crit Care 7 2003 248 251
33. H Li, Q Xia, B Zeng et al. Submassive hepatic necrosis distinguishes HBV-associated acute-on chronic liver failure from cirrhotic patients with acute decompensation J Hepatol 63 2015 50 59
34. P Bellot, R Francés, J Such Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications Liver Int 33 2013 31 39
35. JS Bajaj, JG O'Leary, F Wong, KR Reddy, PS Kamath Bacterial infections in end-stage liver disease: current challenges and future directions Gut 61 2012 1219 1225
36. R Jalan, J Fernandez, R Wiest et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013 J Hepatol 60 2014 1310 1324
37. V Arvaniti, G D'Amico, G Fede et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis Gastroenterology 139 2010 1246 1256
38. T Gustot, P Felleiter, P Pickkers the EPIC II group of investigators Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study Liver Int 34 2014 1496 1503
39. MG Foreman, DM Mannino, M Moss Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey Chest 124 2003 1016 1020
40. J Fernández, T Gustot Management of bacterial infections in cirrhosis J Hepatol 56 suppl 1 2012 S1 S12
41. T Gustot, F Durand, D Lebrec, J-L Vincent, R Moreau Severe sepsis in cirrhosis Hepatology 50 2009 2022 2033
42. HD Nischalke, C Berger, K Aldenhoff et al. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis J Hepatol 55 2011 1010 1016
43. M Merli, C Lucidi, V Giannelli et al. Cirrhotic patients are at risk for health care-associated bacterial infections Clin Gastroenterol Hepatol 8 2010 979 985
44. LJ Markwick, A Riva, JM Ryan et al. Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis Gastroenterology 148 2015 590 602
45. C Bernsmeier, OT Pop, A Singanayagam et al. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK Gastroenterology 148 2015 603 615
46. HE Wasmuth, D Kunz, E Yagmur et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis J Hepatol 42 2005 195 201
47. G Tritto, Z Bechlis, V Stadlbauer et al. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis J Hepatol 55 2011 574 581
48. NJ Taylor, GK Manakkat Vijay, RD Abeles et al. The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality Aliment Pharmacol Ther 40 2014 705 715
49. N Carbonell, A Pauwels, L Serfaty, O Fourdan, VG Lévy, R Poupon Improved survival after variceal bleeding in patients with cirrhosis over the past two decades Hepatology 40 2004 652 659
50. G Garcia-Tsao, J Bosch Management of varices and variceal hemorrhage in cirrhosis N Engl J Med 362 2010 823 832
51. J O'Brien, C Triantos, AK Burroughs Management of varices in patients with cirrhosis Nat Rev Gastroenterol Hepatol 10 2013 402 412
52. L Hobolth, A Krag, F Bendtsen The recent reduction in mortality from bleeding oesophageal varices is primarily observed from days 1 to 5 Liver Int 30 2010 455 462
53. R De Franchis, VF Baveno the Baveno V Faculty Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 53 2010 762 768
54. J Goulis, D Patch, AK Burroughs Bacterial infection in the pathogenesis of variceal bleeding Lancet 353 1999 139 142
55. U Thalheimer, CK Triantos, DN Samonakis, D Patch, AK Burroughs Infection, coagulation, and variceal bleeding in cirrhosis Gut 54 2005 556 563
56. NC Chavez-Tapia, T Barrientos-Gutierrez, F Tellez-Avila et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review Aliment Pharmacol Ther 34 2011 509 518
57. PH Chen, WC Chen, MC Hou et al. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study J Hepatol 57 2012 1207 1213
58. S Kumar Acharya, P Kumar Sharma, R Singh et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death J Hepatol 46 2007 387 394
59. ML Berres, B Schnyder, E Yagmur et al. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis Liver Int 29 2009 536 543
60. PA Berry, CG Antoniades, MJ Hussain et al. Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis Liver Int 30 2010 733 740
61. PA Berry, CG Antoniades, I Carey et al. Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis Intensive Care Med 37 2011 453 460
62. JS Bajaj, JG O'Leary, KR Reddy, NACSELD et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience Hepatology 56 2012 2328 2335
63. AJ O'Brien, JN Fullerton, KA Massey et al. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2 Nat Med 20 2014 518 523
64. J Altamirano, R Miquel, A Katoonizadeh et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis Gastroenterology 146 2014 1231 1239
65. A Katoonizadeh, W Laleman, C Verslype et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study Gut 59 2010 1561 1569
66. A Rastogi, A Kumar, P Sakhuja et al. Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF) Virchows Arch 459 2011 121 127
67. BE Wildhaber, L Rubbia-Brandt, P Majno et al. Focal ischemic necrosis in advanced biliary atresia cirrhosis Pediatr Transplant 12 2008 487 491
68. T Kamiyama, H Miyakawa, K Tajiri, F Marumo, C Sato Ischemic hepatitis in cirrhosis. Clinical features and prognostic implications J Clin Gastroenterol 22 1996 126 130
69. M Dominguez, R Miquel, J Colmenero et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis Gastroenterology 136 2009 1639 1650
70. L Verbeke, F Nevens, W Laleman Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation Crit Care 15 2011 233
71. P Kubes, WZ Mehal Sterile inflammation in the liver Gastroenterology 143 2012 1158 1172
72. H Grønbaek, TD Sandahl, C Mortensen, H Vilstrup, HJ Møller, S Møller Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis Aliment Pharmacol Ther 36 2012 173 180
73. G Mehta, RP Mookerjee, V Sharma, R Jalan Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure Liver Int 35 2015 724 734
74. RP Mookerjee Acute-on-chronic liver failure: the liver and portal haemodynamics Curr Opin Crit Care 17 2011 170 176
75. N Selvapatt, A Singanayagam, J Wendon, CG Antoniades Understanding infection susceptibility in patients with acute-on-chronic liver failure Intensive Care Med 40 2014 1363 1366
76. G Mehta, T Gustot, RP Mookerjee et al. Inflammation and portal hypertension - the undiscovered country J Hepatol 61 2014 155 163
77. P Mathurin, MR Lucey Management of alcoholic hepatitis J Hepatol 56 suppl 1 2012 S39 S45
78. RP Mookerjee, S Sen, NA Davies, SJ Hodges, R Williams, R Jalan Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis Gut 52 2003 1182 1187
79. JL Vincent, D De Backer Circulatory shock N Engl J Med 369 2013 1726 1734
80. YM Arabi, SI Dara, Z Memish the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis Hepatology 56 2012 2305 2315
81. T Gustot, E Maillart, M Bocci et al. Invasive aspergillosis in patients with severe alcoholic hepatitis J Hepatol 60 2014 267 274
82. A Nazar, M Guevara, M Sitges et al. Left ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction J Hepatol 58 2013 51 57
83. S Møller, JH Henriksen Cirrhotic cardiomyopathy J Hepatol 53 2010 179 190
84. S Wiese, JD Hove, F Bendtsen, S Møller Cirrhotic cardiomyopathy: pathogenesis and clinical relevance Nat Rev Gastroenterol Hepatol 11 2014 177 186
85. L Ruiz-del-Arbol, J Urman, J Fernández et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 38 2003 1210 1218
86. R Garcia-Martinez, P Caraceni, M Bernardi, P Gines, V Arroyo, R Jalan Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications Hepatology 58 2013 1836 1846
87. R Garcia-Martinez, F Andreola, G Mehta et al. Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure J Hepatol 62 2015 799 806
88. E Rodríguez, C Elia, E Solà et al. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis J Hepatol 60 2014 955 961
89. T Thévenot, C Bureau, F Oberti et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial J Hepatol 62 2015 822 830
90. P Ginès, J Fernández, F Durand, F Saliba Management of critically-ill cirrhotic patients J Hepatol 56 suppl 1 2012 S13 S24
91. MH Tsai, YS Peng, YC Chen et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock Hepatology 43 2006 673 681
92. G Fede, L Spadaro, T Tomaselli et al. Adrenocortical dysfunction in liver disease: a systematic review Hepatology 55 2012 1282 1291
93. J Fernández, A Escorsell, M Zabalza et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival Hepatology 44 2006 1288 1295
94. YM Arabi, A Aljumah, O Dabbagh et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial CMAJ 182 2010 1971 1977
95. Chronic Liver Failure Consortium http://www.clifresearch.com/scotch/Home.aspx (accessed Aug 20, 2015).
96. V Das, PY Boelle, A Galbois et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival Crit Care Med 38 2010 2108 2116
97. P Ginès, RW Schrier Renal failure in cirrhosis N Engl J Med 361 2009 1279 1290
98. M Martin-Llahi, M Guevara, A Torre et al. Prognostic importance of the cause of renal failure in patients with cirrhosis Gastroenterology 140 2011 488 496
99. P Angeli, P Ginès, F Wong et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites J Hepatol 62 2015 968 974
100. JM Belcher, AJ Sanyal, AJ Peixoto the TRIBE-AKI Consortium Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury Hepatology 60 2014 622 632
101. J Fernández, M Navasa, R Planas et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis Gastroenterology 133 2007 818 824
102. E Nguyen-Khac, T Thevenot, MA Piquet the AAH-NAC Study Group Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis N Engl J Med 365 2011 1781 1789
103. D Lebrec, D Thabut, F Oberti the Pentocir Group Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis Gastroenterology 138 2010 1755 1762
104. MR Thursz, P Richardson, ME Allison et al. Prednisolone or pentoxifylline for alcoholic hepatitis N Engl J Med 372 2015 1619 1628
105. M Cavallin, PS Kamath, M Merli the Italian Association for the Study of the Liver Study Group on Hepatorenal Syndrome Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial Hepatology 62 2015 567 574
106. P Angeli, A Sanyal, S Moller the International Club of Ascites Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites Liver Int 33 2013 16 23
107. M Martín-Llahí, MN Pépin, M Guevara the TAHRS Investigators Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study Gastroenterology 134 2008 1352 1359
108. LL Gluud, K Christensen, E Christensen, A Krag Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome Hepatology 51 2010 576 584
109. TD Boyer, AJ Sanyal, F Wong et al. Initial report of a large, randomized, double blind, placebo-controlled, phase 3 trial of terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome (HRS-1): the REVERSE study Hepatology 60 2014 255A
110. J Fichet, E Mercier, O Genée et al. Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy J Crit Care 24 2009 364 370
111. M Romero-Gómez, S Montagnese, R Jalan Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure J Hepatol 62 2015 437 447
112. D Joshi, J O'Grady, A Patel et al. Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy Liver Int 34 2014 362 366
113. DL Shawcross, Y Sharifi, JB Canavan et al. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis J Hepatol 54 2011 640 649
114. V Khungar, F Poordad Management of overt hepatic encephalopathy Clin Liver Dis 16 2012 73 89
115. B Als-Nielsen, LL Gluud, C Gluud Nonabsorbable disaccharides for hepatic encephalopathy Cochrane Database Syst Rev 2 2004 CD003044.
116. J Córdoba, J López-Hellín, M Planas et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study J Hepatol 41 2004 38 43
117. RS Rahimi, AG Singal, JA Cuthbert, DC Rockey Lactulose vs polyethylene glycol 3350 - electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial JAMA Intern Med 174 2014 1727 1733
118. NA Davies, G Wright, LM Ytrebø et al. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats Hepatology 50 2009 155 164
119. R Bañares, F Nevens, FS Larsen the RELIEF study group Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial Hepatology 57 2013 1153 1162
120. TI Hassanein, F Tofteng, RS Brown Jr et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis Hepatology 46 2007 1853 1862
121. B Terjung, I Lemnitzer, FL Dumoulin et al. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors Digestion 67 2003 138 145
122. CM Grabau, SF Crago, LK Hoff et al. Performance standards for therapeutic abdominal paracentesis Hepatology 40 2004 484 488
123. JB Segal, WH Dzik the Transfusion Medicine/Hemostasis Clinical Trials Network Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review Transfusion 45 2005 1413 1425
124. PD Weeder, RJ Porte, T Lisman Hemostasis in liver disease: implications of new concepts for perioperative management Transfus Med Rev 28 2014 107 113
125. A Tripodi, PM Mannucci The coagulopathy of chronic liver disease N Engl J Med 365 2011 147 156
126. WM Lee, RT Stravitz, AM Larson Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011 Hepatology 55 2012 965 967
127. DF O'Shaughnessy, C Atterbury, P Bolton Maggs the British Committee for Standards in Haematology Blood Transfusion Task Force Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant Br J Haematol 126 2004 11 28
128. T Lisman, TN Bongers, J Adelmeijer et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity Hepatology 44 2006 53 61
129. A Tripodi, M Primignani, V Chantarangkul et al. Thrombin generation in patients with cirrhosis: the role of platelets Hepatology 44 2006 440 445
130. TM Earl, B Cooil, JE Rubin, RS Chari Cost prediction in liver transplantation using pretransplant donor and recipient characteristics Transplantation 86 2008 238 244
131. MR Foxton, MA Al-Freah, AJ Portal et al. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs Liver Transpl 16 2010 668 677
132. MS Roberts, DC Angus, CL Bryce, Z Valenta, L Weissfeld Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database Liver Transpl 10 2004 886 897
133. PJ Thuluvath, HY Yoo, RE Thompson A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics Liver Transpl 9 2003 527 532
134. M Jacob, LP Copley, JD Lewsey, A Gimson, M Rela, JH van der Meulen the UK and Ireland Liver Transplant Audit Functional status of patients before liver transplantation as a predictor of posttransplant mortality Transplantation 80 2005 52 57
135. P Mathurin, C Moreno, D Samuel et al. Early liver transplantation for severe alcoholic hepatitis N Engl J Med 365 2011 1790 1800
136. GK Bonney, MA Aldersley, S Asthana et al. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience Transplantation 87 2009 1858 1863
137. MF Levy, PS Somasundar, LW Jennings et al. The elderly liver transplant recipient: a call for caution Ann Surg 233 2001 107 113
138. CJ Karvellas, T Lescot, P Goldberg the Canadian Liver Failure Study Group Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort study Crit Care 17 2013 R28
139. AB Massie, EKH Chow, CE Wickliffe et al. Early changes in liver distribution following implementation of Share 35 Am J Transplant 15 2015 659 667
140. B Carpentier, A Gautier, C Legallais Artificial and bioartificial liver devices: present and future Gut 58 2009 1690 1702
141. B Struecker, N Raschzok, IM Sauer Liver support strategies: cutting-edge technologies Nat Rev Gastroenterol Hepatol 11 2014 166 176
142. P Krisper, B Haditsch, R Stauber et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation J Hepatol 43 2005 451 457
143. A Kribben, G Gerken, S Haag et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure Gastroenterology 142 2012 782 789